Overview

Avidination for RadionuclideTHerapy in Nonpalpable Breast Cancer

Status:
TERMINATED
Trial end date:
2025-01-30
Target enrollment:
Participant gender:
Summary
This is an interventional, open-label, non comparative phase 2 trial enrolling patients with nonpalpable breast cancer
Phase:
PHASE1
Details
Lead Sponsor:
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS